Literature DB >> 18946774

The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families.

Michael C Monuteaux1, Stephen V Faraone, Paul Hammerness, Timothy E Wilens, Maria Fraire, Joseph Biederman.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a strong risk factor for smoking. Since both ADHD and smoking are familial disorders, one way to further our understanding of this association is to examine the familial relationship between them. Our aim was to evaluate the familial association between ADHD and smoking in families ascertained from girls with and without ADHD. Subjects were derived from a longitudinal case-control family study of girls with (n = 140) and without (n = 122) ADHD ascertained from pediatric and psychiatric clinics, and their biological first-degree relatives. Diagnoses of ADHD and smoking (i.e., full or subthreshold nicotine dependence) were made with structured psychiatric interviews. We stratified the relatives into four groups based on probands' ADHD and smoking status: (1) relatives of controls without smoking (probands n = 100, relatives n = 317), (2) relatives of controls with smoking (probands n = 22, relatives n = 71), (3) relatives of ADHD girls without smoking (probands n = 100, relatives n = 320), and (4) relatives of ADHD girls with smoking (probands n = 39, relatives n = 133). We compared the rates of ADHD and smoking across the four relative groups using survival analysis. ADHD in the proband increased the risk for ADHD in the relatives irrespective of probands' smoking and smoking in the proband increased the risk for smoking in the relatives irrespective of probands' ADHD status. Furthermore, we found statistically significant evidence for cosegregation of smoking and ADHD, suggesting that the two disorders are transmitted together through families more often than expected by chance. These findings support the hypothesis that the combination of ADHD and smoking comprises an etiologically distinct familial subtype of ADHD in girls.

Entities:  

Mesh:

Year:  2008        PMID: 18946774     DOI: 10.1080/14622200802326137

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  10 in total

1.  Attention deficit/hyperactivity disorder symptoms and depression symptoms as mediators in the intergenerational transmission of smoking.

Authors:  Alex Zoloto; Craig T Nagoshi; Clark Presson; Laurie Chassin
Journal:  Drug Alcohol Depend       Date:  2012-06-08       Impact factor: 4.492

2.  Genome-wide association study of smoking initiation and current smoking.

Authors:  Jacqueline M Vink; August B Smit; Eco J C de Geus; Patrick Sullivan; Gonneke Willemsen; Jouke-Jan Hottenga; Johannes H Smit; Witte J Hoogendijk; Frans G Zitman; Leena Peltonen; Jaakko Kaprio; Nancy L Pedersen; Patrik K Magnusson; Tim D Spector; Kirsten Ohm Kyvik; Katherine I Morley; Andrew C Heath; Nicholas G Martin; Rudi G J Westendorp; P Eline Slagboom; Henning Tiemeier; Albert Hofman; Andre G Uitterlinden; Yurii S Aulchenko; Najaf Amin; Cornelia van Duijn; Brenda W Penninx; Dorret I Boomsma
Journal:  Am J Hum Genet       Date:  2009-03-05       Impact factor: 11.025

3.  The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study.

Authors:  Zheng Chang; Paul Lichtenstein; Henrik Larsson
Journal:  J Abnorm Child Psychol       Date:  2012-04

4.  Cigarette smoking in obsessive-compulsive disorder and unaffected parents of OCD patients.

Authors:  Amitai Abramovitch; Diego A Pizzagalli; Daniel A Geller; Lillian Reuman; Sabine Wilhelm
Journal:  Eur Psychiatry       Date:  2014-03-14       Impact factor: 5.361

5.  Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.

Authors:  Annabeth P Groenman; Corina U Greven; Marjolein M J van Donkelaar; Arnt Schellekens; Kimm J E van Hulzen; Nanda Rommelse; Catharina A Hartman; Pieter J Hoekstra; Marjolein Luman; Barbara Franke; Stephen V Faraone; Jaap Oosterlaan; Jan K Buitelaar
Journal:  Addict Biol       Date:  2015-03-06       Impact factor: 4.280

6.  Childhood attention-deficit/hyperactivity disorder symptoms and the development of adolescent alcohol problems: A prospective, population-based study of Swedish twins.

Authors:  Patrick D Quinn; Erik Pettersson; Sebastian Lundström; Henrik Anckarsäter; Niklas Långström; Clara Hellner Gumpert; Henrik Larsson; Paul Lichtenstein; Brian M D'Onofrio
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-12-30       Impact factor: 3.568

7.  Familial confounding of the association between maternal smoking during pregnancy and ADHD in offspring.

Authors:  Charlotte Skoglund; Qi Chen; Brian M D'Onofrio; Paul Lichtenstein; Henrik Larsson
Journal:  J Child Psychol Psychiatry       Date:  2013-07-30       Impact factor: 8.982

Review 8.  Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

Authors:  Steve S Lee; Kathryn L Humphreys; Kate Flory; Rebecca Liu; Kerrie Glass
Journal:  Clin Psychol Rev       Date:  2011-01-20

9.  Emotional, behavioural problems and cigarette smoking in adolescence: findings of a Greek cross-sectional study.

Authors:  George Giannakopoulos; Chara Tzavara; Christine Dimitrakaki; Gerasimos Kolaitis; Vasiliki Rotsika; Yannis Tountas
Journal:  BMC Public Health       Date:  2010-02-03       Impact factor: 3.295

10.  A genome-wide association study of alcohol-dependence symptom counts in extended pedigrees identifies C15orf53.

Authors:  J-C Wang; T Foroud; A L Hinrichs; N X H Le; S Bertelsen; J P Budde; O Harari; D L Koller; L Wetherill; A Agrawal; L Almasy; A I Brooks; K Bucholz; D Dick; V Hesselbrock; E O Johnson; S Kang; M Kapoor; J Kramer; S Kuperman; P A F Madden; N Manz; N G Martin; J N McClintick; G W Montgomery; J I Nurnberger; M Rangaswamy; J Rice; M Schuckit; J A Tischfield; J B Whitfield; X Xuei; B Porjesz; A C Heath; H J Edenberg; L J Bierut; A M Goate
Journal:  Mol Psychiatry       Date:  2012-10-23       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.